ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 226 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,000 | +5.2% | 18,325 | +1.0% | 0.01% | -15.4% |
| Q2 2023 | $229,000 | -3.4% | 18,147 | 0.0% | 0.01% | -18.8% |
| Q1 2023 | $237,000 | -25.9% | 18,147 | 0.0% | 0.02% | -33.3% |
| Q4 2022 | $320,000 | +17.2% | 18,147 | +1.2% | 0.02% | -31.4% |
| Q3 2022 | $273,000 | +2.6% | 17,934 | 0.0% | 0.04% | -7.9% |
| Q2 2022 | $266,000 | -34.2% | 17,934 | 0.0% | 0.04% | -38.7% |
| Q1 2022 | $404,000 | +14.8% | 17,934 | -6.0% | 0.06% | -3.1% |
| Q4 2021 | $352,000 | +13.2% | 19,080 | -17.9% | 0.06% | -81.6% |
| Q3 2021 | $311,000 | -39.5% | 23,232 | -16.3% | 0.35% | -40.5% |
| Q2 2021 | $514,000 | +23.3% | 27,772 | 0.0% | 0.58% | +28.1% |
| Q1 2021 | $417,000 | +4.0% | 27,772 | 0.0% | 0.46% | +46.8% |
| Q4 2020 | $401,000 | -7.2% | 27,772 | -47.7% | 0.31% | +7.3% |
| Q3 2020 | $432,000 | – | 53,075 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |